ViaLase Inc. announced that the first patient has been treated in an investigational device exemption (IDE) clinical trial ...
Ophthalmologists have raised concerns about a bill in the New Hampshire State House that would expand laser treatment certifications for optometrists, according to a Dec. 9 report from ABC affiliate ...
TO SEE THINGS THE WAY OF THE OPTOMETRISTS OR THE OPHTHALMOLOGISTS AT THE STATEHOUSE. IT IS A PUBLIC POLICY WAR, LARGELY INVISIBLE TO PATIENTS OR THE PUBLIC. BUT EYE DOCTORS HAVE BEEN LOCKED IN AN ...
TO SEE THINGS THE WAY OF THE OPTOMETRISTS OR THE OPHTHALMOLOGISTS AT THE STATEHOUSE. IT IS A PUBLIC POLICY WAR, LARGELY INVISIBLE TO PATIENTS OR THE PUBLIC. BUT EYE DOCTORS HAVE BEEN LOCKED IN AN ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient ...
Department of Ophthalmology, Denipol Hospital, Denizli, Turkey. Cyclophotocoagulation entails the destruction of the ciliary body's secretory epithelium to reduce aqueous humor production [3]-[6].
1 Eye School of Chengdu University of Traditional Chinese Medicine, Chengdu, China 2 Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China Background/Objectives: Primary ...
London residents suffering from the sight-threatening eye condition glaucoma can now access speedy care – within just two ...
DEAR DR. ROACH: I am a 77-year-old woman in good health. I walk daily. The only prescribed medications I am on are two different eye drops for glaucoma. My eye pressure is under control; I have it ...
A panelist discusses how combining cataract surgery with canaloplasty and trabeculotomy using the Via360 device offered an effective MIGS solution for a patient with open-angle glaucoma and poor ...
Background/ Aims The lack of context for anterior segment optical coherence tomography (ASOCT) measurements impedes its clinical utility. We established the normative distribution of anterior chamber ...